Source: GlobalNewswire

Press Release: LogicBio : ROSEN, A RANKED AND LEADING FIRM, Reminds LogicBio Therapeutics, Inc. Investors of the Important May 18th Deadline in Securities Class Action - LOGC

NEW YORK, April 15, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of LogicBio Therapeutics, Inc. (NASDAQ: LOGC) between December 3, 2018 and February 10, 2020, inclusive (the "Class Period") of the important May 18, 2020 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for LogicBio investors under the federal securities laws.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Frederic Chereau's photo - President & CEO of LogicBio

President & CEO

Frederic Chereau

CEO Approval Rating

82/100

LogicBio is a biotechnology company that develops genetic medicines to treat rare pediatric diseases. Read more